by
Tate Herbert
| 04/29/2014
An audit of Brandeis' use of federal funding for its Prescription Drug Monitoring Program Center of Excellence claimed that $608,646 of four separate cooperative agreements-awards similar to grants-totaling $3,826,950 and awarded from 2008 to 2011, were "unallowable" or "unsupported" expenses, according to spending guidelines established by the Office of Justice Programs. The most recent award was due to end on March 31 of this year. While the audit, conducted by the Office of Justice Programs and the Office of the Inspector General, concluded that while the PDMP Center of Excellence met its goals, it recommended that Brandeis "remedy" the entirety of the questioned costs.
Trouble in Paradise: Sense and Sensibility’s Virtues and Theater Sins
Brandeis’ 2026 commencement choice is a cowardly, hypocritical cash grab
Growing uncertainty about East Quad's future raises speculation
Brandeis community reflects on antisemitism and campus support
Atlanta Hawks’ strip club-themed promotional night receives pushback from players